Fischer Medical Ventures Limited
NSE: FISCHERINE771F01041·Healthcare·www.fischerchemic.in ↗·Mcap ₹2,293 Cr·Listed 2025
₹34.29▲ ₹0.06  (0.18%)
52W: ₹31 – ₹122 · Vol: 8.9L shares · Close 25 Sept
Set Alert

Quarterly results

consolidated · as filed with NSE · Q1 FY27 back to Q1 FY26
₹ croreQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26
Revenue from operations81.997.710186.323.4
Other income1.51.31.12.57.5
Total expenses75.610180.971.520.6
EBITDA11.3121.616.34.3
EBITDA margin13.7%1.0%21.3%18.8%18.2%
Finance costs3.53.60.60.90.7
Depreciation1.40.90.80.50.8
Profit before tax7.8−2.321.217.310.3
Tax44.923.45.2
Net profit3.8−7.119.213.95
Net margin4.6%-7.3%19.0%16.1%21.4%
EPS (₹)0.06-0.110.302.150.77
Net profit YoY−24.3%––––

Annual results

financial years ending March · from the fourth-quarter filings
₹ croreFY26
Revenue from operations309
Other income12.3
Total expenses274
EBITDA43.1
EBITDA margin14.0%
Finance costs5.8
Depreciation3
Profit before tax46.6
Tax15.3
Net profit31
Net margin10.1%
EPS (₹)0.48
EPS is as filed for each period and is not restated for later bonus issues or splits.

Cash flow

annual · ₹ crore
₹ croreFY26
Operating cash flow−138
Investing cash flow10.4
Financing cash flow34.6
Capital expenditure9.6
Free cash flow (CFO − capex)−147

Net profit trend

annual, ₹ crore
FY26
₹31

Result filings

as filed with NSE · PDF and XBRL
PeriodBasisFiledDocuments
Q1 FY27Consolidated14 Aug 2026PDF on NSE XBRL
Q1 FY27Standalone14 Aug 2026PDF on NSE XBRL
Q4 FY26Consolidated · audited–PDF on NSE XBRL
Q4 FY26Consolidated · audited–PDF on NSE XBRL
Q4 FY26Consolidated · audited31 May 2026PDF on NSE XBRL
Q4 FY26Standalone · audited31 May 2026PDF on NSE XBRL
Q4 FY26Standalone · audited–PDF on NSE XBRL
Q3 FY26Consolidated30 Jan 2026PDF on NSE XBRL
Q3 FY26Standalone30 Jan 2026PDF on NSE XBRL
Q2 FY26Consolidated29 Oct 2025PDF on NSE XBRL

Annual reports

NSE archive
Key ratios
P/E (TTM)5Y avg 85.5×75.3×
P/B5Y avg 13.53×5.82×
ROEFY26, on average equity8.0%
Net margin10.1%
Debt / equity0.19×
Revenue CAGR (3Y)–
Profit CAGR (3Y)–
EPS (TTM)₹0.46
Market cap₹2,244 Cr
Computed from the filings and the last close. Market cap uses the latest share count from the balance sheet.
P/B vs history
5.82×
vs 2-point avg 13.53× (−57%)
5.82× low13.53× avg20.19× high
History points are balance-sheet dates (2025 → 2026), priced at the adjusted close on each date.
Balance sheet 31 Mar 2026
Total assets₹672 Cr
Net worth₹386 Cr
Total borrowings₹72 Cr
Cash & bank balances₹12 Cr
Investments₹123 Cr
Inventories₹13 Cr
Trade receivables₹289 Cr
Trade payables₹103 Cr
Change vs the same date a year earlier.
Shareholding 17 Aug 2026
%Aug 26Jun 26Mar 26Dec 25Sept 25Sept 25Jul 25Jun 25
Promoter63.0862.1562.1561.8061.8061.8061.8061.80
FII5.575.484.974.855.575.615.555.55
DII1.261.351.381.361.421.421.421.42
Retail23.8324.3324.9226.1426.2926.2326.4626.48
Other public6.266.696.585.854.924.944.774.75
23,951 shareholders · NSE shareholding pattern filings.